# Xilio Therapeutics, Inc. (XLO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/XLO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 44.81M | $ -35.87M | $ -5.64M | $ 6.95M | $ 35.27M |
| 2024 | $ 6.67M | $ -61.22M | $ -19.35M | $ 8.14M | $ 17.60M |
| 2023 | $ 0 | $ -82.61M | $ -74.72M | $ 11.46M | $ 36.83M |
| 2022 | $ 0 | $ -98.55M | $ -86.68M | $ 19.94M | $ 105.65M |
| 2021 | $ 0 | $ -90.10M | $ -97.29M | $ 20.74M | $ 185.43M |
| 2020 | $ 0 | $ -70.35M | $ -30.40M | $ 21.89M | $ -5.29M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.20 |
| Liabilities / Eq | 3.39 |
| Current Ratio | 2.58 |

## Other views

- [Metrics](https://sponda.capital/en/XLO.md)
- [Charts](https://sponda.capital/en/XLO/charts.md)
- [Compare](https://sponda.capital/en/XLO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.